| Dr Zabeer Bhatti, MD | |
|
3140 Princeton Pike Fl 2, Lawrenceville, NJ 08648-2330 | |
| (609) 895-1919 | |
| Not Available |
| Full Name | Dr Zabeer Bhatti |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 9 Years |
| Location | 3140 Princeton Pike Fl 2, Lawrenceville, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619354701 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Capital Health Regional Medical Center | Trenton, NJ | Hospital |
| Capital Health Medical Center - Hopewell | Pennington, NJ | Hospital |
| Nyack Hospital | Nyack, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cogent Medical Care Pc | 7315836780 | 170 |
| Capital Health Medical Group | 7618264532 | 364 |
| Capital Health Medical Group | 7618264532 | 364 |
News Archive
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the quarter and nine months ended December 31, 2009. All results are reported in Canadian dollars unless otherwise stated.
ImmunoCellular Therapeutics, Ltd. announced an agreement with Pure MHC, an Emergent Technologies portfolio company, for development of a novel assay for quality control that will be an important component of ImmunoCellular's ICT-107 phase 3 registrational clinical program in newly diagnosed glioblastoma, anticipated to begin in the second half of 2015.
Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country's first gene therapy, Novartis' Kymriah, a leukemia treatment approved in August.
"The decision from the Treasury Department and the Internal Revenue Service means that the income of legally married same-sex couples will be considered in determining eligibility for enrollment in the health law's Medicaid expansion and for subsidies to purchase coverage in the law's online marketplaces, or exchanges" (Carey, 8/30).
› Verified 6 days ago
| Entity Name | Cogent Medical Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912941238 PECOS PAC ID: 7315836780 Enrollment ID: O20040312001215 |
News Archive
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the quarter and nine months ended December 31, 2009. All results are reported in Canadian dollars unless otherwise stated.
ImmunoCellular Therapeutics, Ltd. announced an agreement with Pure MHC, an Emergent Technologies portfolio company, for development of a novel assay for quality control that will be an important component of ImmunoCellular's ICT-107 phase 3 registrational clinical program in newly diagnosed glioblastoma, anticipated to begin in the second half of 2015.
Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country's first gene therapy, Novartis' Kymriah, a leukemia treatment approved in August.
"The decision from the Treasury Department and the Internal Revenue Service means that the income of legally married same-sex couples will be considered in determining eligibility for enrollment in the health law's Medicaid expansion and for subsidies to purchase coverage in the law's online marketplaces, or exchanges" (Carey, 8/30).
› Verified 6 days ago
| Entity Name | Crouse Health Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841340205 PECOS PAC ID: 9739173774 Enrollment ID: O20040413000018 |
News Archive
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the quarter and nine months ended December 31, 2009. All results are reported in Canadian dollars unless otherwise stated.
ImmunoCellular Therapeutics, Ltd. announced an agreement with Pure MHC, an Emergent Technologies portfolio company, for development of a novel assay for quality control that will be an important component of ImmunoCellular's ICT-107 phase 3 registrational clinical program in newly diagnosed glioblastoma, anticipated to begin in the second half of 2015.
Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country's first gene therapy, Novartis' Kymriah, a leukemia treatment approved in August.
"The decision from the Treasury Department and the Internal Revenue Service means that the income of legally married same-sex couples will be considered in determining eligibility for enrollment in the health law's Medicaid expansion and for subsidies to purchase coverage in the law's online marketplaces, or exchanges" (Carey, 8/30).
› Verified 6 days ago
| Entity Name | Hospitalist Medicine Physicians Of New York Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205944329 PECOS PAC ID: 5597767129 Enrollment ID: O20070209000383 |
News Archive
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the quarter and nine months ended December 31, 2009. All results are reported in Canadian dollars unless otherwise stated.
ImmunoCellular Therapeutics, Ltd. announced an agreement with Pure MHC, an Emergent Technologies portfolio company, for development of a novel assay for quality control that will be an important component of ImmunoCellular's ICT-107 phase 3 registrational clinical program in newly diagnosed glioblastoma, anticipated to begin in the second half of 2015.
Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country's first gene therapy, Novartis' Kymriah, a leukemia treatment approved in August.
"The decision from the Treasury Department and the Internal Revenue Service means that the income of legally married same-sex couples will be considered in determining eligibility for enrollment in the health law's Medicaid expansion and for subsidies to purchase coverage in the law's online marketplaces, or exchanges" (Carey, 8/30).
› Verified 6 days ago
| Entity Name | Sound Physicians Of New York Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174962245 PECOS PAC ID: 8628202231 Enrollment ID: O20131015001809 |
News Archive
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the quarter and nine months ended December 31, 2009. All results are reported in Canadian dollars unless otherwise stated.
ImmunoCellular Therapeutics, Ltd. announced an agreement with Pure MHC, an Emergent Technologies portfolio company, for development of a novel assay for quality control that will be an important component of ImmunoCellular's ICT-107 phase 3 registrational clinical program in newly diagnosed glioblastoma, anticipated to begin in the second half of 2015.
Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country's first gene therapy, Novartis' Kymriah, a leukemia treatment approved in August.
"The decision from the Treasury Department and the Internal Revenue Service means that the income of legally married same-sex couples will be considered in determining eligibility for enrollment in the health law's Medicaid expansion and for subsidies to purchase coverage in the law's online marketplaces, or exchanges" (Carey, 8/30).
› Verified 6 days ago
| Entity Name | White Plains Hospital Medical Center |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1992255392 PECOS PAC ID: 4981593092 Enrollment ID: O20161219001743 |
News Archive
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the quarter and nine months ended December 31, 2009. All results are reported in Canadian dollars unless otherwise stated.
ImmunoCellular Therapeutics, Ltd. announced an agreement with Pure MHC, an Emergent Technologies portfolio company, for development of a novel assay for quality control that will be an important component of ImmunoCellular's ICT-107 phase 3 registrational clinical program in newly diagnosed glioblastoma, anticipated to begin in the second half of 2015.
Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country's first gene therapy, Novartis' Kymriah, a leukemia treatment approved in August.
"The decision from the Treasury Department and the Internal Revenue Service means that the income of legally married same-sex couples will be considered in determining eligibility for enrollment in the health law's Medicaid expansion and for subsidies to purchase coverage in the law's online marketplaces, or exchanges" (Carey, 8/30).
› Verified 6 days ago
| Entity Name | East Post Road Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841767274 PECOS PAC ID: 6406198506 Enrollment ID: O20190419000178 |
News Archive
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the quarter and nine months ended December 31, 2009. All results are reported in Canadian dollars unless otherwise stated.
ImmunoCellular Therapeutics, Ltd. announced an agreement with Pure MHC, an Emergent Technologies portfolio company, for development of a novel assay for quality control that will be an important component of ImmunoCellular's ICT-107 phase 3 registrational clinical program in newly diagnosed glioblastoma, anticipated to begin in the second half of 2015.
Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country's first gene therapy, Novartis' Kymriah, a leukemia treatment approved in August.
"The decision from the Treasury Department and the Internal Revenue Service means that the income of legally married same-sex couples will be considered in determining eligibility for enrollment in the health law's Medicaid expansion and for subsidies to purchase coverage in the law's online marketplaces, or exchanges" (Carey, 8/30).
› Verified 6 days ago
| Entity Name | Hospitalist Medicine Physician Of New York - Nyack Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083193262 PECOS PAC ID: 4486987302 Enrollment ID: O20190610000122 |
News Archive
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the quarter and nine months ended December 31, 2009. All results are reported in Canadian dollars unless otherwise stated.
ImmunoCellular Therapeutics, Ltd. announced an agreement with Pure MHC, an Emergent Technologies portfolio company, for development of a novel assay for quality control that will be an important component of ImmunoCellular's ICT-107 phase 3 registrational clinical program in newly diagnosed glioblastoma, anticipated to begin in the second half of 2015.
Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country's first gene therapy, Novartis' Kymriah, a leukemia treatment approved in August.
"The decision from the Treasury Department and the Internal Revenue Service means that the income of legally married same-sex couples will be considered in determining eligibility for enrollment in the health law's Medicaid expansion and for subsidies to purchase coverage in the law's online marketplaces, or exchanges" (Carey, 8/30).
› Verified 6 days ago
| Entity Name | Hospitalist Medicine Physicians Of New York - Patchogue Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366920993 PECOS PAC ID: 6406183821 Enrollment ID: O20190808000333 |
News Archive
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the quarter and nine months ended December 31, 2009. All results are reported in Canadian dollars unless otherwise stated.
ImmunoCellular Therapeutics, Ltd. announced an agreement with Pure MHC, an Emergent Technologies portfolio company, for development of a novel assay for quality control that will be an important component of ImmunoCellular's ICT-107 phase 3 registrational clinical program in newly diagnosed glioblastoma, anticipated to begin in the second half of 2015.
Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country's first gene therapy, Novartis' Kymriah, a leukemia treatment approved in August.
"The decision from the Treasury Department and the Internal Revenue Service means that the income of legally married same-sex couples will be considered in determining eligibility for enrollment in the health law's Medicaid expansion and for subsidies to purchase coverage in the law's online marketplaces, or exchanges" (Carey, 8/30).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Zabeer Bhatti, MD 41 E Post Rd, White Plains, NY 10601-4699 Ph: (914) 681-0600 | Dr Zabeer Bhatti, MD 3140 Princeton Pike Fl 2, Lawrenceville, NJ 08648-2330 Ph: (609) 895-1919 |
News Archive
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the quarter and nine months ended December 31, 2009. All results are reported in Canadian dollars unless otherwise stated.
ImmunoCellular Therapeutics, Ltd. announced an agreement with Pure MHC, an Emergent Technologies portfolio company, for development of a novel assay for quality control that will be an important component of ImmunoCellular's ICT-107 phase 3 registrational clinical program in newly diagnosed glioblastoma, anticipated to begin in the second half of 2015.
Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country's first gene therapy, Novartis' Kymriah, a leukemia treatment approved in August.
"The decision from the Treasury Department and the Internal Revenue Service means that the income of legally married same-sex couples will be considered in determining eligibility for enrollment in the health law's Medicaid expansion and for subsidies to purchase coverage in the law's online marketplaces, or exchanges" (Carey, 8/30).
› Verified 6 days ago
Michael Roy Dash, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 123 Franklin Corner Rd, Suite 216, Lawrenceville, NJ 08648 Phone: 609-895-6800 Fax: 609-895-6988 | |
Dr. Neel Jitendra Gandhi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2997 Princeton Pike, #201, Lawrenceville, NJ 08648 Phone: 609-771-0700 Fax: 609-771-8466 | |
Dr. Humaira Naseem Adenwalla, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3100 Princeton Pike Ste D, Lawrenceville, NJ 08648 Phone: 609-910-5556 | |
Dr. Sarah Anne Werbel, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3100 Princeton Pike, Bldg 4, Suite I, Lawrenceville, NJ 08648 Phone: 609-896-0303 Fax: 609-896-0308 | |
Dr. Robert Silverbrook, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3131 Princeton Pike, Suite204, Lawrenceville, NJ 08648 Phone: 609-306-8924 Fax: 215-364-3139 | |
Mrs. Daphne Duvalsaint Dadzie, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 168 Franklin Corner Rd, Building 1, Suite 2a, Lawrenceville, NJ 08648 Phone: 609-896-0075 Fax: 609-896-0079 | |
Dr. Jason Hollander, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 168 Franklin Corner Rd Bldg 1, Lawrenceville, NJ 08648 Phone: 609-924-4433 Fax: 609-924-4423 |